Skip to Content

Tests and vaccines push Walgreens past expectations in 2Q

By TOM MURPHY
AP Health Writer

A surge in demand for COVID-19 tests and vaccines helped Walgreens deliver a better fiscal second quarter than Wall Street expected.  The drugstore chain said store sales jumped as customers bought at-home COVID-19 tests. Vaccines also boosted pharmacy sales as the omicron surge for the virus peaked during the quarter.  Sales of virus-related products also helped Walgreens in the previous quarter. Overall, Walgreens  reported adjusted earnings of $1.59 per share in the quarter that ended Feb. 28. Revenue climbed about 3% to $33.76 billion.Analysts expect, on average, earnings of $1.39 per share on $33.23 billion in revenue, according to FactSet.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content